CERS 8-K: Leadership Transition Brings CEO to Chair Role

Rhea-AI Filing Summary

Cerus Corporation (CERS) filed a Form 8-K to announce a governance change effective June 16, 2025. Long-standing board chair Daniel N. Swisher, Jr. retired from the board and its committees with no reported disagreements over company matters. To maintain continuity, the board moved quickly on June 20 to promote CEO William M. Greenman to chair while appointing Frank Witney, Ph.D. as lead independent director. Both directors will serve in their existing board classes, expiring at the 2026 and 2027 annual meetings, respectively. No other operational or financial data were disclosed in the filing.

The change consolidates the CEO and chair roles, offset by the creation of a lead independent director position intended to preserve board oversight. Investors should view the update as a routine succession matter with limited immediate financial impact but modest corporate-governance implications.

Positive

• Orderly transition: Retirement cited no disagreements, suggesting stability.
• Lead independent director appointed, offering continued oversight despite CEO also becoming chair.

Negative

• CEO and chair roles combined, potentially reducing board independence.
• Loss of veteran chair Daniel Swisher could dilute experienced governance insights.

Insights

Corporate Governance Expert

TL;DR: CEO becomes chair; lead independent named—neutral governance shift, minimal near-term impact.

The retirement of Mr. Swisher removes an experienced independent voice, but the board mitigates this by designating CEO Greenman as chair and appointing Dr. Witney as lead independent director. Combining chair and CEO can raise oversight concerns; however, many mid-cap biotech firms use this structure. Because there is no reported disagreement and the lead independent role is formalized, I classify the net effect as governance-neutral. No financial guidance or strategic changes accompany the move, so material impact on valuation is low.

Portfolio Manager

TL;DR: Leadership shuffle only; investment thesis unchanged.

This 8-K does not alter Cerus’s cash-burn profile, revenue trajectory, or clinical pipeline. Governance watchers may flag the dual CEO/chair role, but the added lead independent director tempers that risk. In absence of operational updates, I view the disclosure as not impactful to near-term stock performance and retain my prior position sizing.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): June 16, 2025

CERUS CORPORATION

(Exact Name of Registrant as Specified in Charter)

Delaware		000-21937		68-0262011
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

1220 Concord Ave, Suite 600 Concord, California		94520
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code (925) 288-6000

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

	☐	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	☐	Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	☐	Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.001 per share		CERS		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 16, 2025, Daniel N. Swisher, Jr., chair of the board of directors (the “Board”) of Cerus Corporation (the “Company”), notified the Company of his intent to retire from the Board and all committees thereof on which he served, effective immediately. Mr. Swisher’s decision to retire from the Board was not because of a disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

In connection with Mr. Swisher’s retirement, on June 20, 2025, the Board appointed William M. Greenman, the Company’s President and Chief Executive Officer and a member of the class of directors whose terms of office expire at the Company’s 2026 annual meeting of stockholders, to serve as chair of the Board and Frank Witney, Ph.D., a member of the class of directors whose terms of office expire at the Company’s 2027 annual meeting of stockholders, to serve as the Board’s lead independent director, in each case effective immediately.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: June 23, 2025				CERUS CORPORATION
				By:		/s/ Chrystal N. Jensen
				Chrystal N. Jensen
				Chief Legal Officer, General Counsel and Secretary

3

FAQ

Why did CERS file an 8-K on June 23 2025?

To disclose the retirement of board chair Daniel Swisher and subsequent board leadership changes.

Did Daniel Swisher resign due to a dispute with Cerus Corporation?

No. The filing states he retired voluntarily and without disagreement on company matters.

Who is the new chair of the Cerus (CERS) board?

President & CEO William M. Greenman was appointed chair effective June 20 2025.

What independent oversight remains after the CEO became chair?

The board designated Frank Witney, Ph.D. as lead independent director to maintain oversight.

Does the 8-K include any financial or earnings information?

No financial, earnings, or operational metrics were provided in this filing.